-
1
-
-
28744446343
-
ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the american college of cardiology/american heart association task force on practice guidelines writing committee to update the 2001 guidelines for the evaluation and management of heart failure
-
Hunt SA, Abraham WT, Chin MH et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112(12), e154-e235 (2005)
-
(2005)
Circulation
, vol.112
, Issue.12
-
-
Hunt, S.A.1
Abraham, W.T.2
Chin, M.H.3
-
2
-
-
17944374924
-
Guidelines for the diagnosis and treatment of chronic heart failure
-
DOI 10.1053/euhj.2001.2783
-
Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur. Heart J. 22(17), 1527-1560 (2001) (Pubitemid 32801300)
-
(2001)
European Heart Journal
, vol.22
, Issue.17
, pp. 1527-1560
-
-
Remme, W.J.1
Swedberg, K.2
-
3
-
-
0342460492
-
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia
-
Anker SD, Chua TP, Ponikowski P et al. Hormonal changes and catabolic/ anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96(2), 526-534 (1997) (Pubitemid 27329429)
-
(1997)
Circulation
, vol.96
, Issue.2
, pp. 526-534
-
-
Anker, S.D.1
Chua, T.P.2
Ponikowski, P.3
Harrington, D.4
Swan, J.W.5
Kox, W.J.6
Poole-Wilson, P.A.7
Coats, A.J.S.8
-
5
-
-
69949113078
-
Heart failure as a multiple hormonal deficiency syndrome
-
Sacca L. Heart failure as a multiple hormonal deficiency syndrome. Circ. Heart Fail. 2(2), 151-156 (2009)
-
(2009)
Circ. Heart Fail.
, vol.2
, Issue.2
, pp. 151-156
-
-
Sacca, L.1
-
6
-
-
70449644857
-
The GH/IGF-1 axis and heart failure
-
Castellano G, Affuso F, Conza PD, Fazio S. The GH/IGF-1 axis and heart failure. Curr. Cardiol. Rev. 5(3), 203-215 (2009)
-
(2009)
Curr. Cardiol. Rev.
, vol.5
, Issue.3
, pp. 203-215
-
-
Castellano, G.1
Affuso, F.2
Conza, P.D.3
Fazio, S.4
-
7
-
-
0026702877
-
Physiology of growth hormone secretion and action
-
Casanueva FF. Physiology of growth hormone secretion and action. Endocrinol. Metab. Clin. North Am. 21(3), 483-517 (1992)
-
(1992)
Endocrinol. Metab. Clin. North Am.
, vol.21
, Issue.3
, pp. 483-517
-
-
Casanueva, F.F.1
-
8
-
-
49649106996
-
The GH-IGF-I axis and the cardiovascular system: Clinical implications
-
Oxf.
-
Colao A. The GH-IGF-I axis and the cardiovascular system: clinical implications. Clin. Endocrinol. (Oxf.) 69(3), 347-358 (2008)
-
(2008)
Clin. Endocrinol.
, vol.69
, Issue.3
, pp. 347-358
-
-
Colao, A.1
-
9
-
-
0034803527
-
Insulin-like growth factor 1 (IGF-1): A growth hormone
-
DOI 10.1136/mp.54.5.311
-
Laron Z. Insulin-like growth factor 1 (IGF-1): a growth hormone. Mol. Pathol. 54(5), 311-316 (2001) (Pubitemid 32928257)
-
(2001)
Journal of Clinical Pathology - Molecular Pathology
, vol.54
, Issue.5
, pp. 311-316
-
-
Laron, Z.1
-
10
-
-
0035115172
-
Growth hormone and the heart
-
DOI 10.1046/j.1365-2265.2001.01218.x
-
Colao A, Marzullo P, Di Somma C, Lombardi G. Growth hormone and the heart. Clin. Endocrinol. (Oxf.) 54(2), 137-154 (2001) (Pubitemid 32194446)
-
(2001)
Clinical Endocrinology
, vol.54
, Issue.2
, pp. 137-154
-
-
Colao, A.1
Marzullo, P.2
Di Somma, C.3
Lombardi, G.4
-
11
-
-
0027970820
-
Growth hormone and the heart
-
DOI 10.1210/er.15.5.555
-
Sacca L, Cittadini A, Fazio S. Growth hormone and the heart. Endocr. Rev. 15(5), 555-573 (1994) (Pubitemid 24328207)
-
(1994)
Endocrine Reviews
, vol.15
, Issue.5
, pp. 555-573
-
-
Sacca, L.1
Cittadini, A.2
Fazio, S.3
-
12
-
-
0032514277
-
2+ through a wortmannin-sensitive pathway: Studies in rat and ferret isolated muscles
-
2+ through a wortmannin-sensitive pathway: studies in rat and ferret isolated muscles. Circ. Res. 83(1), 50-59 (1998) (Pubitemid 28322099)
-
(1998)
Circulation Research
, vol.83
, Issue.1
, pp. 50-59
-
-
Cittadini, A.1
Ishiguro, Y.2
Stromer, H.3
Spindler, M.4
Moses, A.C.5
Clark, R.6
Douglas, P.S.7
Ingwall, J.S.8
Morgan, J.P.9
-
13
-
-
0027976585
-
Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells
-
Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC, Goligorsky MS. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int. 45(2), 598-604 (1994) (Pubitemid 24065099)
-
(1994)
Kidney International
, vol.45
, Issue.2
, pp. 598-604
-
-
Tsukahara, H.1
Gordienko, D.V.2
Tonshoff, B.3
Gelato, M.C.4
Goligorsky, M.S.5
-
14
-
-
0034714437
-
Insulin-like growth factor I retards apoptotic signaling induced by ethanol in cardiomyocytes
-
Chen DB, Wang L, Wang PH. Insulin-like growth factor I retards apoptotic signaling induced by ethanol in cardiomyocytes. Life Sci. 67(14), 1683-1693 (2000)
-
(2000)
Life Sci.
, vol.67
, Issue.14
, pp. 1683-1693
-
-
Chen, D.B.1
Wang, L.2
Wang, P.H.3
-
15
-
-
0033951649
-
The insulin-like growth factor axis: A review of atherosclerosis and restenosis
-
Bayes-Genis A, Conover CA, Schwartz RS. The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circ. Res. 86(2), 125-130 (2000) (Pubitemid 30086171)
-
(2000)
Circulation Research
, vol.86
, Issue.2
, pp. 125-130
-
-
Bayes-Genis, A.1
Conover, C.A.2
Schwartz, R.S.3
-
16
-
-
0036064285
-
Growth hormone deficiency and vascular risk
-
DOI 10.1046/j.1365-2265.2002.01559.x
-
McCallum RW, Petrie JR, Dominiczak AF, Connell JM. Growth hormone deficiency and vascular risk. Clin. Endocrinol. (Oxf.) 57(1), 11-24 (2002) (Pubitemid 34785878)
-
(2002)
Clinical Endocrinology
, vol.57
, Issue.1
, pp. 11-24
-
-
McCallum, R.W.1
Petrie, J.R.2
Dominiczak, A.F.3
Connell, J.M.C.4
-
17
-
-
33745218966
-
Beginning to end: Cardiovascular implications of growth hormone GH deficiency and GH therapy
-
A
-
Colao A, Di Somma C, Savanelli MC, De Leo M, Lombardi G. Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy. Growth Horm. IGF Res. 16(Suppl. A), S41-S48 (2006)
-
(2006)
Growth Horm. IGF Res.
, vol.16
-
-
Colao, A.1
Di Somma, C.2
Savanelli, M.C.3
De Leo, M.4
Lombardi, G.5
-
18
-
-
0026715187
-
The growth hormone deficiency syndrome in adults
-
Oxf.
-
Cuneo RC, Salomon F, McGauley GA, Sonksen PH. The growth hormone deficiency syndrome in adults. Clin. Endocrinol. (Oxf.) 37(5), 387-397 (1992)
-
(1992)
Clin. Endocrinol.
, vol.37
, Issue.5
, pp. 387-397
-
-
Cuneo, R.C.1
Salomon, F.2
McGauley, G.A.3
Sonksen, P.H.4
-
19
-
-
8244225987
-
Increased arterial intima-media thickness in childhood-onset growth hormone deficiency
-
Capaldo B, Patti L, Oliviero U et al. Increased arterial intima-media thickness in childhood-onset growth hormone deficiency. J. Clin. Endocrinol. Metab. 82(5), 1378-1381 (1997) (Pubitemid 27200404)
-
(1997)
Journal of Clinical Endocrinology and Metabolism
, vol.82
, Issue.5
, pp. 1378-1381
-
-
Capaldo, B.1
Patti, L.2
Oliviero, U.3
Longobardi, S.4
Pardo, F.5
Vitale, F.6
Fazio, S.7
Di Rella, F.8
Biondi, B.9
Lombardi, G.10
Sacca, L.11
-
20
-
-
0031914569
-
Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency
-
DOI 10.1046/j.1365-2265.1998.00281.x
-
Longobardi S, Cuocolo A, Merola B et al. Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency. Clin. Endocrinol. (Oxf.) 48(2), 137-143 (1998) (Pubitemid 28091042)
-
(1998)
Clinical Endocrinology
, vol.48
, Issue.2
, pp. 137-143
-
-
Longobardi, S.1
Cuocolo, A.2
Merola, B.3
Di Rella, F.4
Colao, A.5
Nicolai, E.6
Cardei, S.7
Salvatore, M.8
Lombardi, G.9
-
21
-
-
0028006779
-
Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults
-
Thuesen L, Jorgensen JO, Muller JR et al. Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults. Clin. Endocrinol. (Oxf.) 41(5), 615-620 (1994) (Pubitemid 24336864)
-
(1994)
Clinical Endocrinology
, vol.41
, Issue.5
, pp. 615-620
-
-
Thuesen, L.1
Jorgensen, O.L.2
Muller, J.R.3
Kristensen, B.O.4
Skakkebaek, N.E.5
Vahl, N.6
Christiansen, J.S.7
-
22
-
-
0028843243
-
Cardiac performance and mass in adults with hypopituitarism: Effects of one year of growth hormone treatment
-
Valcavi R, Gaddi O, Zini M et al. Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment. J. Clin. Endocrinol. Metab. 80(2), 659-666 (1995)
-
(1995)
J. Clin. Endocrinol. Metab.
, vol.80
, Issue.2
, pp. 659-666
-
-
Valcavi, R.1
Gaddi, O.2
Zini, M.3
-
23
-
-
0033306840
-
Impaired cardiac performance in elderly patients with growth hormone deficiency
-
Colao A, Cuocolo A, Di Somma C et al. Impaired cardiac performance in elderly patients with growth hormone deficiency. J. Clin. Endocrinol. Metab. 84(11), 3950-3955 (1999) (Pubitemid 30644179)
-
(1999)
Journal of Clinical Endocrinology and Metabolism
, vol.84
, Issue.11
, pp. 3950-3955
-
-
Colao, A.1
Cuocolo, A.2
Di Somma, C.3
Cerbone, G.4
Della Morte, A.M.5
Nicolai, E.6
Lucci, R.7
Salvatore, M.8
Lombardi, G.9
-
24
-
-
10344237010
-
The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: An observational, case-control study
-
DOI 10.1210/jc.2004-1042
-
Colao A, Di Somma C, Cuocolo A et al. The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: an observational, case-control study. J. Clin. Endocrinol. Metab. 89(12), 5998-6004 (2004) (Pubitemid 39628406)
-
(2004)
Journal of Clinical Endocrinology and Metabolism
, vol.89
, Issue.12
, pp. 5998-6004
-
-
Colao, A.1
Di Somma, C.2
Cuocolo, A.3
Filippella, M.4
Rota, F.5
Acampa, W.6
Savastano, S.7
Salvatore, M.8
Lombardi, G.9
-
25
-
-
2442526224
-
Impact of Growth Hormone (GH) Treatment on Cardiovascular Risk Factors in GH-Deficient Adults: A Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials
-
DOI 10.1210/jc.2003-030840
-
Maison P, Griffin S, Nicoue-Beglah M et al. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. J. Clin. Endocrinol. Metab. 89(5), 2192-2199 (2004) (Pubitemid 38619852)
-
(2004)
Journal of Clinical Endocrinology and Metabolism
, vol.89
, Issue.5
, pp. 2192-2199
-
-
Maison, P.1
Griffin, S.2
Nicoue-Beglah, M.3
Haddad, N.4
Balkau, B.5
Chanson, P.6
-
26
-
-
0027140982
-
Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses
-
DOI 10.1210/jc.77.6.1671
-
Amato G, Carella C, Fazio S et al. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J. Clin. Endocrinol. Metab. 77(6), 1671-1676 (1993). (Pubitemid 24000933)
-
(1993)
Journal of Clinical Endocrinology and Metabolism
, vol.77
, Issue.6
, pp. 1671-1676
-
-
Amato, G.1
Carella, C.2
Fazio, S.3
La Montagna, G.4
Cittadini, A.5
Sabatini, D.6
Marciano-Mone, C.7
Sacca, L.8
Bellastella, A.9
-
27
-
-
0033306143
-
Long-term effects of growth hormone GH replacement in men with childhood-onset GH deficiency
-
ter Maaten JC, de Boer H, Kamp O, Stuurman L, van der Veen EA. Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency. J. Clin. Endocrinol. Metab. 84(7), 2373-2380 (1999)
-
(1999)
J. Clin. Endocrinol. Metab.
, vol.84
, Issue.7
, pp. 2373-2380
-
-
Ter Maaten, J.C.1
De Boer, H.2
Kamp, O.3
Stuurman, L.4
Van Der Veen, E.A.5
-
28
-
-
0035726804
-
Commencing growth hormone replacement in adults with a fixed low dose. Effects on serum lipoproteins, glucose metabolism, body composition, and cardiovascular function
-
DOI 10.1054/ghir.2001.0240
-
Gillberg P, Bramnert M, Thoren M, Werner S, Johannsson G. Commencing growth hormone replacement in adults with a fixed low dose. Effects on serum lipoproteins, glucose metabolism, body composition, and cardiovascular function. Growth Horm IGF Res. 11(5), 273-281 (2001) (Pubitemid 34262639)
-
(2001)
Growth Hormone and IGF Research
, vol.11
, Issue.5
, pp. 273-281
-
-
Gillberg, P.1
Bramnert, M.2
Thoren, M.3
Werner, S.4
Johannsson, G.5
-
29
-
-
0033345441
-
The effects of 10 years of recombinant human growth hormone (GH) in adult (GH)-deficient patients
-
Gibney J, Wallace JD, Spinks T et al. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients. J. Clin. Endocrinol. Metab. 84(8), 2596-2602 (1999) (Pubitemid 30641978)
-
(1999)
Journal of Clinical Endocrinology and Metabolism
, vol.84
, Issue.8
, pp. 2596-2602
-
-
Gibney, J.1
Wallace, J.D.2
Spinks, T.3
Schnorr, L.4
Ranicar, A.5
Cuneo, R.C.6
Lockhart, S.7
Burnand, K.G.8
Salomon, F.9
Sonksen, P.H.10
Russell-Jones, D.11
-
30
-
-
0028868301
-
Effect of growth hormone hGH replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood
-
Nass R, Huber RM, Klauss V et al. Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. J. Clin. Endocrinol. Metab. 80(2), 552-557 (1995)
-
(1995)
J. Clin. Endocrinol. Metab.
, vol.80
, Issue.2
, pp. 552-557
-
-
Nass, R.1
Huber, R.M.2
Klauss, V.3
-
31
-
-
12244261599
-
Hormonal profile in patients with congestive heart failure
-
DOI 10.1016/S0167-5273(02)00212-7, PII S0167527302002127
-
Kontoleon PE, Anastasiou-Nana MI, Papapetrou PD et al. Hormonal profile in patients with congestive heart failure. Int. J. Cardiol. 87(2-3), 179-183 (2003) (Pubitemid 36135974)
-
(2003)
International Journal of Cardiology
, vol.87
, Issue.2-3
, pp. 179-183
-
-
Kontoleon, P.E.1
Anastasiou-Nana, M.I.2
Papapetrou, P.D.3
Alexopoulos, G.4
Ktenas, V.5
Rapti, A.C.6
Tsagalou, E.P.7
Nanas, J.N.8
-
32
-
-
0034456111
-
The severity of chronic heart failure due to coronary artery disease predicts the endocrine effects of short-term growth hormone administration
-
DOI 10.1210/jc.85.4.1533
-
Osterziel KJ, Blum WF, Strohm O, Dietz R. The severity of chronic heart failure due to coronary artery disease predicts the endocrine effects of short-term growth hormone administration. J. Clin. Endocrinol. Metab. 85(4), 1533-1539 (2000) (Pubitemid 32289496)
-
(2000)
Journal of Clinical Endocrinology and Metabolism
, vol.85
, Issue.4
, pp. 1533-1539
-
-
Osterziel, K.J.1
Blum, W.F.2
Strohm, O.3
Dietz, R.4
-
33
-
-
77958604010
-
Insulin-like growth factor axis insulin-like growth factor-I/insulin-like growth factor-binding protein-3 as a prognostic predictor of heart failure: Association with adiponectin
-
Watanabe S, Tamura T, Ono K et al. Insulin-like growth factor axis (insulin-like growth factor-I/insulin-like growth factor-binding protein-3) as a prognostic predictor of heart failure: association with adiponectin. Eur. J. Heart Fail. 12(11), 1214-1222 (2010)
-
(2010)
Eur. J. Heart Fail.
, vol.12
, Issue.11
, pp. 1214-1222
-
-
Watanabe, S.1
Tamura, T.2
Ono, K.3
-
34
-
-
0030890494
-
Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction
-
DOI 10.1016/S0735-1097(97)00010-7, PII S0735109797000107
-
Cittadini A, Grossman JD, Napoli R et al. Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction. J. Am. Coll. Cardiol. 29(5), 1109-1116 (1997) (Pubitemid 27149590)
-
(1997)
Journal of the American College of Cardiology
, vol.29
, Issue.5
, pp. 1109-1116
-
-
Cittadini, A.1
Grossman, J.D.2
Napoli, R.3
Katz, S.E.4
Stromer, H.5
Smith, R.J.6
Clark, R.7
Morgan, J.P.8
Douglas, P.S.9
-
35
-
-
0029051227
-
Growth hormone improves cardiac performance in experimental heart failure
-
Yang R, Bunting S, Gillett N, Clark R, Jin H. Growth hormone improves cardiac performance in experimental heart failure. Circulation 92(2), 262-267 (1995)
-
(1995)
Circulation
, vol.92
, Issue.2
, pp. 262-267
-
-
Yang, R.1
Bunting, S.2
Gillett, N.3
Clark, R.4
Jin, H.5
-
36
-
-
0029949746
-
Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat
-
Duerr RL, McKirnan MD, Gim RD et al. Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. Circulation 93(12), 2188-2196 (1996) (Pubitemid 26187109)
-
(1996)
Circulation
, vol.93
, Issue.12
, pp. 2188-2196
-
-
Duerr, R.L.1
McKirnan, M.D.2
Gim, R.D.3
Clark, R.G.4
Chien, K.R.5
Ross Jr., J.6
-
37
-
-
0038005396
-
Growth hormone prolongs survival in experimental postinfarction heart failure
-
DOI 10.1016/S0735-1097(03)00483-2
-
Cittadini A, Isgaard J, Monti MG et al. Growth hormone prolongs survival in experimental postinfarction heart failure. J. Am. Coll. Cardiol. 41(12), 2154-2163 (2003) (Pubitemid 36733540)
-
(2003)
Journal of the American College of Cardiology
, vol.41
, Issue.12
, pp. 2154-2163
-
-
Cittadini, A.1
Isgaard, J.2
Monti, M.G.3
Casaburi, C.4
Di Gianni, A.5
Serpico, R.6
Iaccarino, G.7
Sacca, L.8
-
38
-
-
0030010229
-
A preliminary study of growth hormone in the treatment of dilated cardiomyopathy
-
DOI 10.1056/NEJM199603283341301
-
Fazio S, Sabatini D, Capaldo B et al. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N. Engl. J. Med. 334(13), 809-814 (1996) (Pubitemid 26099602)
-
(1996)
New England Journal of Medicine
, vol.334
, Issue.13
, pp. 809-814
-
-
Fazio, S.1
Sabatini, D.2
Capaldo, B.3
Vicorito, C.4
Giordano, A.5
Guida, R.6
Pardo, F.7
Biondi, B.8
Sacca, L.9
-
39
-
-
0033547764
-
Recombinant growth hormone therapy in patients with ischemic cardiomyopathy: Effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity
-
Genth-Zotz S, Zotz R, Geil S et al. Recombinant growth hormone therapy in patients with ischemic cardiomyopathy: effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity. Circulation 99(1), 18-21 (1999) (Pubitemid 29035951)
-
(1999)
Circulation
, vol.99
, Issue.1
, pp. 18-21
-
-
Genth-Zotz, S.1
Zotz, R.2
Geil, S.3
Voigtlander, T.4
Meyer, J.5
Darius, H.6
-
40
-
-
0032565361
-
Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
-
DOI 10.1016/S0140-6736(97)11329-0
-
Osterziel KJ, Strohm O, Schuler J et al. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 351(9111), 1233-1237 (1998) (Pubitemid 28181962)
-
(1998)
Lancet
, vol.351
, Issue.9111
, pp. 1233-1237
-
-
Osterziel, K.J.1
Strohm, O.2
Schuler, J.3
Friedrich, M.4
Hanlein, D.5
Willenbrock, R.6
Anker, S.D.7
Poole-Wilson, P.A.8
Ranke, M.B.9
Dietz, R.10
-
41
-
-
0032994536
-
Growth hormone therapy in patients with dilated cardiomyopathy: Preliminary observations of a pilot study
-
Jose VJ, Zechariah TU, George P, Jonathan V. Growth hormone therapy in patients with dilated cardiomyopathy: preliminary observations of a pilot study. Indian Heart J. 51(2), 183-185 (1999) (Pubitemid 29288176)
-
(1999)
Indian Heart Journal
, vol.51
, Issue.2
, pp. 183-185
-
-
Jose, V.J.1
Zechariah, T.U.2
George, P.3
Jonathan, V.4
-
42
-
-
12144288932
-
Six-months of recombinant human GH therapy in patients with ischemic cardiac failure
-
DOI 10.1023/B:CAIM.0000013156.15274.5f
-
van Thiel SW, Smit JW, de Roos A et al. Six-months of recombinant human GH therapy in patients with ischemic cardiac failure. Int. J. Cardiovasc. Imag. 20(1), 53-60 (2004) (Pubitemid 38324839)
-
(2004)
International Journal of Cardiovascular Imaging
, vol.20
, Issue.1
, pp. 53-60
-
-
Van Thiel, S.W.1
Smit, J.W.A.2
De Roos, A.3
Bax, J.J.4
Van Der Wall, E.E.5
Biermasz, N.R.6
Viergever, E.7
Vliegen, H.W.8
Romijn, J.A.9
Roelfsema, F.10
Lamb, H.J.11
-
43
-
-
0344341757
-
Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass
-
DOI 10.1210/jc.86.10.4638
-
Smit JW, Janssen YJ, Lamb HJ et al. Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass. J. Clin. Endocrinol. Metab. 86(10), 4638-4643 (2001) (Pubitemid 33020500)
-
(2001)
Journal of Clinical Endocrinology and Metabolism
, vol.86
, Issue.10
, pp. 4638-4643
-
-
Smit, J.W.A.1
Janssen, Y.J.H.2
Lamb, H.J.3
Van Der Wall, E.E.4
Stokkel, M.P.M.5
Viergever, E.6
Biermasz, N.R.7
Bax, J.J.8
Vliegen, H.W.9
De Roos, A.10
Romijn, J.A.11
Roelfsema, F.12
-
44
-
-
0032213494
-
A placebo-controlled study of growth hormone in patients with congestive heart failure
-
DOI 10.1053/euhj.1998.1123
-
Isgaard J, Bergh CH, Caidahl K et al. A placebo-controlled study of growth hormone in patients with congestive heart failure. Eur. Heart J. 19(11), 1704-1711 (1998) (Pubitemid 28524190)
-
(1998)
European Heart Journal
, vol.19
, Issue.11
, pp. 1704-1711
-
-
Isgaard, J.1
Bergh, C.-H.2
Caidahl, K.3
Lomsky, M.4
Hjalmarson, A.5
Bengtsson, B.-A.6
-
45
-
-
0037305044
-
Administration of growth hormone to patients with advanced cardiac heart failure: Effects upon left ventricular function, exercise capacity, and neurohormonal status
-
DOI 10.1016/S0167-5273(02)00249-8, PII S0167527302002498
-
Acevedo M, Corbalan R, Chamorro G et al. Administration of growth hormone to patients with advanced cardiac heart failure: effects upon left ventricular function, exercise capacity, and neurohormonal status. Int. J. Cardiol. 87(2-3), 185-191 (2003) (Pubitemid 36135975)
-
(2003)
International Journal of Cardiology
, vol.87
, Issue.2-3
, pp. 185-191
-
-
Acevedo, M.1
Corbalan, R.2
Chamorro, G.3
Jalil, J.4
Nazzal, C.5
Campusano, C.6
Castro, P.7
-
46
-
-
0033051329
-
Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness
-
DOI 10.1530/eje.0.1400017
-
Van den Berghe G, Wouters P, Bowers CY et al. Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness. Eur. J. Endocrinol. 140(1), 17-22 (1999) (Pubitemid 29074762)
-
(1999)
European Journal of Endocrinology
, vol.140
, Issue.1
, pp. 17-22
-
-
Van Den Berghe, G.1
Wouters, P.2
Bowers, C.Y.3
De Zegher, F.4
Bouillon, R.5
Veldhuis, J.D.6
-
47
-
-
0032146343
-
Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation
-
DOI 10.1016/S0735-1097(98)00226-5, PII S0735109798002265
-
Niebauer J, Pflaum CD, Clark AL et al. Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J. Am. Coll. Cardiol. 32(2), 393-397 (1998) (Pubitemid 28396488)
-
(1998)
Journal of the American College of Cardiology
, vol.32
, Issue.2
, pp. 393-397
-
-
Niebauer, J.1
Pflaum, C.-D.2
Clark, A.L.3
Strasburger, C.J.4
Hooper, J.5
Poole-Wilson, P.A.6
Coats, A.J.S.7
Anker, S.D.8
-
48
-
-
40649119926
-
Growth hormone therapy in congestive heart failure due to left ventricular systolic dysfunction: A meta-analysis
-
Tritos NA, Danias PG. Growth hormone therapy in congestive heart failure due to left ventricular systolic dysfunction: a meta-analysis. Endocr. Pract. 14(1), 40-49 (2008)
-
(2008)
Endocr. Pract.
, vol.14
, Issue.1
, pp. 40-49
-
-
Tritos, N.A.1
Danias, P.G.2
-
49
-
-
0034897735
-
Acquired growth hormone resistance in patients with chronic heart failure: Implications for therapy with growth hormone
-
DOI 10.1016/S0735-1097(01)01385-7, PII S0735109701013857
-
Anker SD, Volterrani M, Pflaum CD et al. Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J. Am. Coll. Cardiol. 38(2), 443-452 (2001) (Pubitemid 32725023)
-
(2001)
Journal of the American College of Cardiology
, vol.38
, Issue.2
, pp. 443-452
-
-
Anker, S.D.1
Volterrani, M.2
Pflaum, C.-D.3
Strasburger, C.J.4
Osterziel, K.J.5
Doehner, W.6
Ranke, M.B.7
Poole-Wilson, P.A.8
Giustina, A.9
Dietz, R.10
Coats, A.J.S.11
-
50
-
-
0027501201
-
Acquired growth hormone resistance in patients with hypercatabolism
-
Bentham J, Rodriguez-Arnao J, Ross RJ. Acquired growth hormone resistance in patients with hypercatabolism. Horm. Res. 40(1-3), 87-91 (1993) (Pubitemid 23349948)
-
(1993)
Hormone Research
, vol.40
, Issue.1-3
, pp. 87-91
-
-
Bentham, J.1
Rodriguez-Arnao, J.2
Ross, R.J.M.3
-
51
-
-
0029078053
-
Acquired growth hormone resistance
-
Ross RJ, Chew SL. Acquired growth hormone resistance. Eur. J. Endocrinol. 132(6), 655-660 (1995)
-
(1995)
Eur. J. Endocrinol.
, vol.132
, Issue.6
, pp. 655-660
-
-
Ross, R.J.1
Chew, S.L.2
-
53
-
-
0024561857
-
Cardiac failure responding to growth hormone
-
Cuneo RC, Wilmshurst P, Lowy C, McGauley G, Sonksen PH. Cardiac failure responding to growth hormone. Lancet 1(8642), 838-839 (1989) (Pubitemid 19103147)
-
(1989)
Lancet
, vol.1
, Issue.8642
, pp. 838-839
-
-
Cuneo, R.C.1
Wilmshurst, P.2
Lowy, C.3
McGauley, G.4
Sonksen, P.H.5
-
54
-
-
0031565436
-
Treatment of end-state cardiac failure with growth hormone [2]
-
DOI 10.1016/S0140-6736(05)62290-8
-
O'Driscoll JG, Green DJ, Ireland M, Kerr D, Larbalestier RI. Treatment of end-stage cardiac failure with growth hormone. Lancet 349(9058), 1068 (1997) (Pubitemid 27158255)
-
(1997)
Lancet
, vol.349
, Issue.9058
, pp. 1068
-
-
O'Driscoll, J.G.1
Green, D.J.2
Ireland, M.3
Kerr, D.4
Larbalestier, R.I.5
-
55
-
-
0027533214
-
Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously
-
Kupfer SR, Underwood LE, Baxter RC, Clemmons DR. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J. Clin. Invest. 91(2), 391-396 (1993) (Pubitemid 23064118)
-
(1993)
Journal of Clinical Investigation
, vol.91
, Issue.2
, pp. 391-396
-
-
Kupfer, S.R.1
Underwood, L.E.2
Baxter, R.C.3
Clemmons, D.R.4
-
56
-
-
33845503501
-
Systemic metabolic effects of combined insulin-like growth factor-I and growth hormone therapy in patients who have sustained acute traumatic brain injury
-
Hatton J, Kryscio R, Ryan M, Ott L, Young B. Systemic metabolic effects of combined insulin-like growth factor-I and growth hormone therapy in patients who have sustained acute traumatic brain injury. J. Neurosurg. 105(6), 843-852 (2006) (Pubitemid 44917386)
-
(2006)
Journal of Neurosurgery
, vol.105
, Issue.6
, pp. 843-852
-
-
Hatton, J.1
Kryscio, R.2
Ryan, M.3
Linda, O.4
Young, B.5
-
57
-
-
0028324350
-
Clinical uses of insulin-like growth factor I
-
Bondy CA, Underwood LE, Clemmons DR et al. Clinical uses of insulin-like growth factor I. Ann. Intern. Med. 120(7), 593-601 (1994) (Pubitemid 24091602)
-
(1994)
Annals of Internal Medicine
, vol.120
, Issue.7
, pp. 593-601
-
-
Bondy, C.A.1
Underwood, L.E.2
Clemmons, D.R.3
Guler, H.-P.4
Bach, M.A.5
Skarulis, M.6
-
58
-
-
67349149713
-
Advantages and disadvantages of GH/IGF-I combination treatment
-
Janssen JA. Advantages and disadvantages of GH/IGF-I combination treatment. Rev. Endocr. Metab. Disord. 10(2), 157-162 (2009)
-
(2009)
Rev. Endocr. Metab. Disord.
, vol.10
, Issue.2
, pp. 157-162
-
-
Janssen, J.A.1
-
59
-
-
3042773859
-
Therapeutic applications of the insulin-like growth factors
-
DOI 10.1016/j.ghir.2004.04.001, PII S1096637404000735
-
Savage MO, Camacho-Hubner C, Dunger DB. Therapeutic applications of the insulin-like growth factors. Growth Horm. IGF Res. 14(4), 301-308 (2004). (Pubitemid 38878056)
-
(2004)
Growth Hormone and IGF Research
, vol.14
, Issue.4
, pp. 301-308
-
-
Savage, M.O.1
Camacho-Hubner, C.2
Dunger, D.B.3
-
60
-
-
0033023320
-
GH replacement in 1034 growth hormone deficient hypopituitary adults: Demographic and clinical characteristics, dosing and safety
-
DOI 10.1046/j.1365-2265.1999.00695.x
-
Abs R, Bengtsson BA, Hernberg-Stahl E et al. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clin. Endocrinol. (Oxf.) 50(6), 703-713 (1999) (Pubitemid 29284503)
-
(1999)
Clinical Endocrinology
, vol.50
, Issue.6
, pp. 703-713
-
-
Abs, R.1
Bengtsson, B.-A.2
Hernberg-Stahl, E.3
Monson, J.P.4
Tauber, J.-P.5
Wilton, P.6
Wuster, C.7
-
61
-
-
77949497802
-
Treatment of adult growth hormone deficiency: Who why and how a review
-
Alexopoulou O, Abs R, Maiter D. Treatment of adult growth hormone deficiency: who, why and how? A review. Acta Clin. Belg. 65(1), 13-22 (2010)
-
(2010)
Acta Clin. Belg.
, vol.65
, Issue.1
, pp. 13-22
-
-
Alexopoulou, O.1
Abs, R.2
Maiter, D.3
-
62
-
-
0028027050
-
Potential for growth factor treatment of muscle disease
-
Moxley RT 3rd. Potential for growth factor treatment of muscle disease. Curr. Opin. Neurol. 7(5), 427-434 (1994) (Pubitemid 24282688)
-
(1994)
Current Opinion in Neurology
, vol.7
, Issue.5
, pp. 427-434
-
-
Moxley III, R.T.1
-
63
-
-
0033539018
-
Increased mortality associated with growth hormone treatment in critically ill adults
-
DOI 10.1056/NEJM199909093411102
-
Takala J, Ruokonen E, Webster NR et al. Increased mortality associated with growth hormone treatment in critically ill adults. N. Engl. J. Med. 341(11), 785-792 (1999) (Pubitemid 29420473)
-
(1999)
New England Journal of Medicine
, vol.341
, Issue.11
, pp. 785-792
-
-
Takala, J.1
Ruokonen, E.2
Webster, N.R.3
Nielsen, M.S.4
Zandstra, D.F.5
Vundelinckx, G.6
Hinds, C.J.7
-
64
-
-
0033539123
-
Growth hormone therapy in critically ill patients
-
DOI 10.1056/NEJM199909093411110
-
Demling R. Growth hormone therapy in critically ill patients. N. Engl. J. Med. 341(11), 837-839 (1999) (Pubitemid 29420481)
-
(1999)
New England Journal of Medicine
, vol.341
, Issue.11
, pp. 837-839
-
-
Demling, R.1
-
65
-
-
0030724963
-
Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults
-
Johannsson G, Rosen T, Bengtsson BA. Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults. Clin. Endocrinol. (Oxf.) 47(5), 571-581 (1997) (Pubitemid 27496332)
-
(1997)
Clinical Endocrinology
, vol.47
, Issue.5
, pp. 571-581
-
-
Johannsson, G.1
Rosen, T.2
Bengtsson, B.-A.3
-
66
-
-
14444278299
-
Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults
-
Drake WM, Coyte D, Camacho-Hubner C et al. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J. Clin. Endocrinol. Metab. 83(11), 3913-3919 (1998) (Pubitemid 28513572)
-
(1998)
Journal of Clinical Endocrinology and Metabolism
, vol.83
, Issue.11
, pp. 3913-3919
-
-
Drake, W.M.1
Coyte, D.2
Camacho-hubner, C.3
Jivanji, N.M.4
Kaltsas, G.5
Wood, D.F.6
Trainer, P.J.7
Grossman, A.B.8
Besser, G.M.9
Monson, J.P.10
-
67
-
-
0032499440
-
Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
-
DOI 10.1016/S0140-6736(97)10384-1
-
Hankinson SE, Willett WC, Colditz GA et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351(9113), 1393-1396 (1998) (Pubitemid 28209997)
-
(1998)
Lancet
, vol.351
, Issue.9113
, pp. 1393-1396
-
-
Hankinson, S.E.1
Willett, W.C.2
Colditz, G.A.3
Hunter, D.J.4
Michaud, D.S.5
Deroo, B.6
Rosner, B.7
Speizer, F.E.8
Pollak, M.9
-
68
-
-
85011463498
-
Sex hormone-binding globulin mediates prostate androgen receptor action via a novel signaling pathway
-
DOI 10.1210/en.139.1.213
-
Ding VD, Moller DE, Feeney WP et al. Sex hormone-binding globulin mediates prostate androgen receptor action via a novel signaling pathway. Endocrinology 139(1), 213-218 (1998) (Pubitemid 28166311)
-
(1998)
Endocrinology
, vol.139
, Issue.1
, pp. 213-218
-
-
Ding, V.D.H.1
Moller, D.E.2
Feeney, W.P.3
Didolkar, V.4
Nakhla, A.M.5
Rhodes, L.6
Rosner, W.7
Smith, R.G.8
-
69
-
-
0024555077
-
Androgen receptor locus on the human X chromosome: Regional localization to Xq11-12 and description of a DNA polymorphism
-
Brown CJ, Goss SJ, Lubahn DB et al. Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism. Am. J. Hum. Genet. 44(2), 264-269 (1989) (Pubitemid 19045022)
-
(1989)
American Journal of Human Genetics
, vol.44
, Issue.2
, pp. 264-269
-
-
Brown, C.J.1
Goss, S.J.2
Lubahn, D.B.3
Joseph, D.R.4
Wilson, E.M.5
French, F.S.6
Willard, H.F.7
-
70
-
-
0025935923
-
Domains of the human androgen receptor involved in steroid binding transcriptional activation and subcellular localization
-
Jenster G, van der Korput HA, van Vroonhoven C et al. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol. Endocrinol. 5(10), 1396-1404 (1991)
-
(1991)
Mol. Endocrinol.
, vol.5
, Issue.10
, pp. 1396-1404
-
-
Jenster, G.1
Van Der Korput, H.A.2
Van Vroonhoven, C.3
-
71
-
-
0030633188
-
Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action
-
Shibata H, Spencer TE, Onate SA et al. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent. Prog. Horm. Res. 52, 141-164; discussion 164-165 (1997) (Pubitemid 127470209)
-
(1997)
Recent Progress in Hormone Research
, vol.52
, pp. 141-164
-
-
Shibata, H.1
Spencer, T.E.2
Onate, S.A.3
Jenster, G.4
Tsai, S.Y.5
Tsai, M.-J.6
O'Malley, B.W.7
-
72
-
-
77956208593
-
Membrane testosterone receptors in cultured vascular smooth muscle cells
-
Ma R, Jiang SS, Cheng XM et al. [Membrane testosterone receptors in cultured vascular smooth muscle cells]. Zhonghua Nan Ke Xue 16(5), 428-432 (2010)
-
(2010)
Zhonghua. Nan. Ke. Xue.
, vol.16
, Issue.5
, pp. 428-432
-
-
Ma, R.1
Jiang, S.S.2
Cheng, X.M.3
-
73
-
-
0037349115
-
The vasodilatory action of testosterone: A potassium-channel opening or a calcium antagonistic action?
-
DOI 10.1038/sj.bjp.0705141
-
Jones RD, Pugh PJ, Jones TH, Channer KS. The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action? Br. J. Pharmacol. 138(5), 733-744 (2003) (Pubitemid 36390629)
-
(2003)
British Journal of Pharmacology
, vol.138
, Issue.5
, pp. 733-744
-
-
Jones, R.D.1
Pugh, P.J.2
Jones, T.H.3
Channer, K.S.4
-
74
-
-
4043174113
-
Testosterone-induced coronary vasodilatation occurs via a non-genomic mechanism: Evidence of a direct calcium antagonism action
-
DOI 10.1042/CS20030386
-
Jones RD, English KM, Jones TH, Channer KS. Testosterone-induced coronary vasodilatation occurs via a non-genomic mechanism: evidence of a direct calcium antagonism action. Clin. Sci. (Lond.) 107(2), 149-158 (2004) (Pubitemid 39070931)
-
(2004)
Clinical Science
, vol.107
, Issue.2
, pp. 149-158
-
-
Jones, R.D.1
English, K.M.2
Hugh Jones, T.3
Channer, K.S.4
-
75
-
-
0037991446
-
Acute haemodynamic effects of testosterone in men with chronic heart failure
-
DOI 10.1016/S0195-668X(03)00083-6
-
Pugh PJ, Jones TH, Channer KS. Acute haemodynamic effects of testosterone in men with chronic heart failure. Eur. Heart J. 24(10), 909-915 (2003) (Pubitemid 36559984)
-
(2003)
European Heart Journal
, vol.24
, Issue.10
, pp. 909-915
-
-
Pugh, P.J.1
Jones, T.H.2
Channer, K.S.3
-
76
-
-
35848940534
-
Effects of testosterone on cytokines and left ventricular remodeling following heart failure
-
DOI 10.1159/000110444
-
Zhang YZ, Xing XW, He B, Wang LX. Effects of testosterone on cytokines and left ventricular remodeling following heart failure. Cell Physiol. Biochem. 20(6), 847-852 (2007) (Pubitemid 350059727)
-
(2007)
Cellular Physiology and Biochemistry
, vol.20
, Issue.6
, pp. 847-852
-
-
Zhang, Y.-Z.1
Xing, X.-W.2
He, B.3
Wang, L.-X.4
-
77
-
-
77951928138
-
Testosterone therapy improves cardiac function of male rats with right heart failure
-
Li ZB, Wang J, Wang JX, Chen XM, Jiang SS. [Testosterone therapy improves cardiac function of male rats with right heart failure]. Zhonghua Nan Ke Xue 15(11), 994-1000 (2009)
-
(2009)
Zhonghua. Nan. Ke. Xue.
, vol.15
, Issue.11
, pp. 994-1000
-
-
Li, Z.B.1
Wang, J.2
Wang, J.X.3
Chen, X.M.4
Jiang, S.S.5
-
78
-
-
33750548421
-
Anabolic deficiency in men with chronic heart failure: Prevalence and detrimental impact on survival
-
DOI 10.1161/CIRCULATIONAHA.106.649426, PII 0000301720061024000009
-
Jankowska EA, Biel B, Majda J et al. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation 114(17), 1829-1837 (2006) (Pubitemid 44673358)
-
(2006)
Circulation
, vol.114
, Issue.17
, pp. 1829-1837
-
-
Jankowska, E.A.1
Biel, B.2
Majda, J.3
Szklarska, A.4
Lopuszanska, M.5
Medras, M.6
Anker, S.D.7
Banasiak, W.8
Poole-Wilson, P.A.9
Ponikowski, P.10
-
79
-
-
68849113580
-
Neuroendocrine effects on the heart and targets for therapeutic manipulation in heart failure
-
Chaggar PS, Malkin CJ, Shaw SM, Williams SG, Channer KS. Neuroendocrine effects on the heart and targets for therapeutic manipulation in heart failure. Cardiovasc. Ther. 27(3), 187-193 (2009)
-
(2009)
Cardiovasc. Ther.
, vol.27
, Issue.3
, pp. 187-193
-
-
Chaggar, P.S.1
Malkin, C.J.2
Shaw, S.M.3
Williams, S.G.4
Channer, K.S.5
-
80
-
-
77950551563
-
Low circulating androgens and mortality risk in heart failure
-
Guder G, Frantz S, Bauersachs J et al. Low circulating androgens and mortality risk in heart failure. Heart 96(7), 504-509 (2010)
-
(2010)
Heart
, vol.96
, Issue.7
, pp. 504-509
-
-
Guder, G.1
Frantz, S.2
Bauersachs, J.3
-
81
-
-
28944442442
-
Testosterone therapy in men with moderate severity heart failure: A double-blind randomized placebo controlled trial
-
DOI 10.1093/eurheartj/ehi443
-
Malkin CJ, Pugh PJ, West JN et al. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. Eur. Heart J. 27(1), 57-64 (2006) (Pubitemid 41785933)
-
(2006)
European Heart Journal
, vol.27
, Issue.1
, pp. 57-64
-
-
Malkin, C.J.1
Pugh, P.J.2
West, J.N.3
Van Beek, E.J.R.4
Jones, T.H.5
Channer, K.S.6
-
82
-
-
0032948205
-
Effect of oxymetholone on left ventricular dimensions in heart failure secondary to idiopathic dilated cardiomyopathy or to mitral or aortic regurgitation
-
DOI 10.1016/S0002-9149(98)00796-6, PII S0002914998007966
-
Tomoda H. Effect of oxymetholone on left ventricular dimensions in heart failure secondary to idiopathic dilated cardiomyopathy or to mitral or aortic regurgitation. Am. J. Cardiol. 83(1), 123-125, A9 (1999) (Pubitemid 29036661)
-
(1999)
American Journal of Cardiology
, vol.83
, Issue.1
, pp. 123-125
-
-
Tomoda, H.1
-
83
-
-
68949172537
-
Effect of long-acting testosterone treatment on functional exercise capacity skeletal muscle performance insulin resistance and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind placebo-controlled randomized study
-
Caminiti G, Volterrani M, Iellamo F et al. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J. Am. Coll. Cardiol. 54(10), 919-927 (2009)
-
(2009)
J. Am. Coll. Cardiol.
, vol.54
, Issue.10
, pp. 919-927
-
-
Caminiti, G.1
Volterrani, M.2
Iellamo, F.3
-
84
-
-
77957334994
-
Testosterone therapy in women with chronic heart failure: A pilot double-blind randomized placebo-controlled study
-
Iellamo F, Volterrani M, Caminiti G et al. Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. J. Am. Coll. Cardiol. 56(16), 1310-1316 (2010)
-
(2010)
J. Am. Coll. Cardiol.
, vol.56
, Issue.16
, pp. 1310-1316
-
-
Iellamo, F.1
Volterrani, M.2
Caminiti, G.3
-
85
-
-
34248563042
-
Testosterone replacement therapy and prostate cancer: A word of caution
-
DOI 10.1007/s11934-007-0004-x
-
Brand TC, Canby-Hagino E, Thompson IM. Testosterone replacement therapy and prostate cancer: a word of caution. Curr. Urol. Rep. 8(3), 185-189 (2007) (Pubitemid 46806646)
-
(2007)
Current Urology Reports
, vol.8
, Issue.3
, pp. 185-189
-
-
Brand, T.C.1
Canby-Hagino, E.2
Thompson, I.M.3
-
86
-
-
0037241928
-
Testosterone supplementation therapy for older men: Potential benefits and risks
-
DOI 10.1034/j.1601-5215.2002.51018.x
-
Gruenewald DA, Matsumoto AM. Testosterone supplementation therapy for older men: potential benefits and risks. J. Am. Geriatr. Soc. 51(1), 101-115; discussion 115 (2003) (Pubitemid 36119943)
-
(2003)
Journal of the American Geriatrics Society
, vol.51
, Issue.1
, pp. 101-115
-
-
Gruenewald, D.A.1
Matsumoto, A.M.2
-
87
-
-
0031880293
-
The cardiac toxicity of anabolic steroids
-
Sullivan ML, Martinez CM, Gennis P, Gallagher EJ. The cardiac toxicity of anabolic steroids. Prog. Cardiovasc. Dis. 41(1), 1-15 (1998) (Pubitemid 28385246)
-
(1998)
Progress in Cardiovascular Diseases
, vol.41
, Issue.1
, pp. 1-15
-
-
Sullivan, M.L.1
Martinez, C.M.2
Gennis, P.3
Gallagher, E.J.4
-
88
-
-
1642463867
-
Testosterone treatment for men with chronic heart failure
-
Pugh PJ, Jones RD, West JN, Jones TH, Channer KS. Testosterone treatment for men with chronic heart failure. Heart 90(4), 446-447 (2004) (Pubitemid 38406925)
-
(2004)
Heart
, vol.90
, Issue.4
, pp. 446-447
-
-
Pugh, P.J.1
Jones, R.D.2
West, J.N.3
Jones, T.H.4
Channer, K.S.5
-
89
-
-
77954409942
-
Testosterone therapy in men with androgen deficiency syndromes: An endocrine Society clinical practice guideline
-
Bhasin S, Cunningham GR, Hayes FJ et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 95(6), 2536-2559 (2010)
-
(2010)
J. Clin. Endocrinol. Metab.
, vol.95
, Issue.6
, pp. 2536-2559
-
-
Bhasin, S.1
Cunningham, G.R.2
Hayes, F.J.3
-
90
-
-
77954421915
-
Adverse events associated with testosterone administration
-
Basaria S, Coviello AD, Travison TG et al. Adverse events associated with testosterone administration. N. Engl. J. Med. 363(2), 109-122 (2010)
-
(2010)
N. Engl. J. Med.
, vol.363
, Issue.2
, pp. 109-122
-
-
Basaria, S.1
Coviello, A.D.2
Travison, T.G.3
-
91
-
-
0026593243
-
Serum cholesterol blood pressure cigarette smoking and death from coronary heart disease overall findings and differences by age for 316099 white men
-
Multiple Risk Factor Intervention Trial Research Group
-
Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch. Intern. Med. 152(1), 56-64 (1992)
-
(1992)
Arch. Intern. Med.
, vol.152
, Issue.1
, pp. 56-64
-
-
Neaton, J.D.1
Wentworth, D.2
-
92
-
-
66749140429
-
Testosterone and growth hormone improve body composition and muscle performance in older men
-
Sattler FR, Castaneda-Sceppa C, Binder EF et al. Testosterone and growth hormone improve body composition and muscle performance in older men. J. Clin. Endocrinol. Metab. 94(6), 1991-2001 (2009)
-
(2009)
J. Clin. Endocrinol. Metab.
, vol.94
, Issue.6
, pp. 1991-2001
-
-
Sattler, F.R.1
Castaneda-Sceppa, C.2
Binder, E.F.3
-
93
-
-
0036924729
-
Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men
-
DOI 10.1210/jc.2002-020098
-
Brill KT, Weltman AL, Gentili A et al. Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men. J. Clin. Endocrinol. Metab. 87(12), 5649-5657 (2002). (Pubitemid 36034373)
-
(2002)
Journal of Clinical Endocrinology and Metabolism
, vol.87
, Issue.12
, pp. 5649-5657
-
-
Brill, K.T.1
Weltman, A.L.2
Gentili, A.3
Patrie, J.T.4
Fryburg, D.A.5
Hanks, J.B.6
Urban, R.J.7
Veldhuis, J.D.8
|